Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

Hisashi Saji(St. Marianna University School of Medicine), Morihito Okada(Hiroshima University), Masahiro Tsuboi(National Cancer Center Hospital East), Ryu Nakajima(Osaka City General Hospital), Kenji Suzuki(Juntendo University), Keiju Aokage(National Cancer Center Hospital East), Tadashi Aoki(Niigata Cancer Center Hospital), Jiro Okami(Osaka Medical Center for Cancer and Cardiovascular Diseases), Ichiro Yoshino(Chiba University), Hiroyuki Ito(Kanagawa Prefectural Hospital Organization), Norihito Okumura(Kurashiki Central Hospital), Masafumi Yamaguchi(National Hospital Organization Kyushu Cancer Center), Norihiko Ikeda(Tokyo Medical University), Masashi Wakabayashi(Japan Clinical Cancer Research Organization), Kenichi Nakamura(Japan Clinical Cancer Research Organization), Haruhiko Fukuda(Japan Clinical Cancer Research Organization), Shinichiro Nakamura(Japan Clinical Cancer Research Organization), Tetsuya Mitsudomi(Kindai University), Shun‐ichi Watanabe(Tokyo National Hospital), Hisao Asamura(Keio University)
The Lancet
April 1, 2022
Cited by 1,617

Abstract


Related Papers

No related papers found

Powered by citation graph analysis